Advisory Services Network’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-294
Closed -$27.2K 3159
2026
Q1
$27.2K Buy
+294
New +$29.5K ﹤0.01% 3003
2025
Q4
Sell
-169
Closed -$10.6K 2786
2025
Q3
$10.6K Buy
+169
New +$9.19K ﹤0.01% 3262
2024
Q1
Sell
-139
Closed -$3.75K 2311
2023
Q4
$3.75K Buy
+139
New +$3.65K ﹤0.01% 3210
2023
Q2
Sell
-153
Closed -$3.59K 2296
2023
Q1
$3.59K Buy
153
+1
+0.7% +$29 ﹤0.01% 3256
2022
Q4
$4.13K Buy
+152
New +$6.96K ﹤0.01% 3188
2021
Q3
Sell
-190
Closed -$24K 2126
2021
Q2
$24K Buy
+190
New +$25.6K ﹤0.01% 2418
2021
Q1
Sell
-163
Closed -$21K 1940
2020
Q4
$21K Buy
163
+54
+50% +$6.21K ﹤0.01% 2120
2020
Q3
$12K Buy
+109
New +$9.97K ﹤0.01% 2332
2020
Q2
Sell
-432
Closed -$30K 1692
2020
Q1
$30K Buy
+432
New +$33.2K ﹤0.01% 1632

Other funds holding GH

Advisory Services Network's GH Position: Q2 2026 in Review

Advisory Services Network sold out of Guardant Health (GH) in Q2 2026, closing a stake of 294 shares — an estimated $27.2K sold.

Advisory Services Network first reported a position in GH in Q1 2020 and held it in 9 quarters. The position peaked at $30K in Q1 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Advisory Services Network reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 294 Guardant Health shares in Q2 2026, an estimated $27.2K.
  • Advisory Services Network first reported a position in Guardant Health in Q1 2020 and held it in 9 quarters.
  • Advisory Services Network's Guardant Health position peaked at $30K in Q1 2020.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.